The vascular contributions to neurodegeneration and neuroinflammation may be assessed by magnetic resonance imaging (MRI) and ultrasonography (US). This review summarises the methodology for these widely available, safe and relatively low cost tools and analyses recent work highlighting their potential utility as biomarkers for differentiating subtypes of cognitive impairment and dementia, tracking disease progression and evaluating response to treatment in various neurocognitive disorders
We aim to estimate brain tissue displacements in the medial temporal lobe (MTL) using backscattered ...
Background Although cerebral white matter lesions (WMLs) are considered as a risk factor for vascula...
Neurovascular dysfunction, including blood-brain barrier (BBB) breakdown and cerebral blood flow (CB...
Background: The vascular contributions to neurodegeneration and neuroinflammation may be assessed by...
The vascular contributions to neurodegeneration and neuroinflammation may be assessed by magnetic re...
Fifty million people worldwide are affected by dementia, a heterogeneous neurodegenerative condition...
International audienceFifty million people worldwide are affected by dementia, a heterogeneous neuro...
Although transcranial sonography is not yet an established diagnostic modality for dementia screenin...
BACKGROUND: Multiple lines of evidence suggest that cardiovascular co-morbidities hasten the onset o...
This dissertation describes the development and validation of a new biomarker, based on engineering ...
Cerebrovascular Assessment for the Risk Prediction of Alzheimer's Disease. Silvestrini M, Viticch...
Cerebrovascular diseases are well established causes of cognitive impairment. Different etiologic en...
ABSTRACT. The last decade has witnessed substantial progress in acquiring diagnostic biomarkers for ...
The paper provides data on current neuroimaging techniques for diagnosing Alzheimer’s disease and va...
We aim to estimate brain tissue displacements in the medial temporal lobe (MTL) using backscattered ...
Background Although cerebral white matter lesions (WMLs) are considered as a risk factor for vascula...
Neurovascular dysfunction, including blood-brain barrier (BBB) breakdown and cerebral blood flow (CB...
Background: The vascular contributions to neurodegeneration and neuroinflammation may be assessed by...
The vascular contributions to neurodegeneration and neuroinflammation may be assessed by magnetic re...
Fifty million people worldwide are affected by dementia, a heterogeneous neurodegenerative condition...
International audienceFifty million people worldwide are affected by dementia, a heterogeneous neuro...
Although transcranial sonography is not yet an established diagnostic modality for dementia screenin...
BACKGROUND: Multiple lines of evidence suggest that cardiovascular co-morbidities hasten the onset o...
This dissertation describes the development and validation of a new biomarker, based on engineering ...
Cerebrovascular Assessment for the Risk Prediction of Alzheimer's Disease. Silvestrini M, Viticch...
Cerebrovascular diseases are well established causes of cognitive impairment. Different etiologic en...
ABSTRACT. The last decade has witnessed substantial progress in acquiring diagnostic biomarkers for ...
The paper provides data on current neuroimaging techniques for diagnosing Alzheimer’s disease and va...
We aim to estimate brain tissue displacements in the medial temporal lobe (MTL) using backscattered ...
Background Although cerebral white matter lesions (WMLs) are considered as a risk factor for vascula...
Neurovascular dysfunction, including blood-brain barrier (BBB) breakdown and cerebral blood flow (CB...